• Profile
Close

Effect of 6 months of flash glucose monitoring in youth with type 1 diabetes and high-risk control: A randomized controlled trial

Diabetes Care Aug 18, 2020

Boucher SE, Gray AR, Wiltshire EJ, et al. - This multicenter 6-month randomized, controlled, parallel-arm trial was undertaken to determine if intermittently scanned continuous glucose monitoring (isCGM) significantly enhance glycemic control compared with capillary self-monitored blood glucose (SMBG) in youth with type 1 diabetes and high-risk glycemic control. The sample consisted of 64 candidates, aged 13 to 20 years, with established type 1 diabetes and glycated hemoglobin ≥ 9% (≥ 75 mmol/mol). According to findings, isCGM contributed to improvements in glucose testing frequency and diabetes treatment satisfaction for youth with high-risk glycemic control. These did not, however, lead to a greater improvement in glycemic control over usual SMBG care at 6 months.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay